Preliminary data release for randomized clinical trials of noninferiority: A new proposal

被引:17
作者
Korn, EL
Hunsberger, S
Freidlin, B
Smith, MA
Abrams, JS
机构
[1] NCI, Biometr Res Branch, Bethesda, MD 20892 USA
[2] NCI, Clin Invest Branch, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
关键词
D O I
10.1200/JCO.2005.02.105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Noninferiority trials often require a long follow-up period for the data to reach the maturity needed for definitive analysis. A proposal is presented that allows for early release of outcome data from a carefully specified subset of noninferiority trials. This subset is defined so that the early release of the data will be potentially useful to patients who face a treatment decision but will not compromise the integrity of the trial or interfere with the completion of the trial to its definitive analysis. In particular, the release of the data will only occur after the last participant has been randomly assigned and is off treatment-arm-specific therapy and only if it is unlikely that subsequent treatment and/or follow-up practices will change based on the knowledge of released data. In contrast to standard interim monitoring, (1) the release of the data would be automatic and independent of the observed data, and (2) the trial would continue on to its planned final analysis and not be stopped. Examples are given demonstrating how the proposal would work, along with a discussion of possible objections to the proposal.
引用
收藏
页码:5831 / 5836
页数:6
相关论文
共 10 条
[1]   PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].
BLACKWELDER, WC .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353
[2]   PLANNING AND MONITORING OF EQUIVALENCE STUDIES [J].
DURRLEMAN, S ;
SIMON, R .
BIOMETRICS, 1990, 46 (02) :329-336
[3]   DESIGNS FOR GROUP SEQUENTIAL-TESTS [J].
FLEMING, TR ;
HARRINGTON, DP ;
OBRIEN, PC .
CONTROLLED CLINICAL TRIALS, 1984, 5 (04) :348-361
[4]   Data monitoring committees and interim monitoring guidelines [J].
Freidlin, B ;
Korn, EL ;
George, SL .
CONTROLLED CLINICAL TRIALS, 1999, 20 (05) :395-407
[5]   REPEATED ASSESSMENT OF RESULTS IN CLINICAL TRIALS OF CANCER TREATMENT [J].
HAYBITTLE, JL .
BRITISH JOURNAL OF RADIOLOGY, 1971, 44 (526) :793-+
[6]  
JENNISON C, 1989, J R STAT SOC B, V51, P305
[7]   DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL-TRIALS [J].
LAN, KKG ;
DEMETS, DL .
BIOMETRIKA, 1983, 70 (03) :659-663
[8]   MULTIPLE TESTING PROCEDURE FOR CLINICAL-TRIALS [J].
OBRIEN, PC ;
FLEMING, TR .
BIOMETRICS, 1979, 35 (03) :549-556
[9]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1976, 34 (06) :585-612
[10]   Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 1: Ethical and scientific issues [J].
Temple, R ;
Ellenberg, SS .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) :455-463